
Addressing the current hurdles and potential solutions in nonalcoholic steatohepatitis awareness and clinical trial enrollment.
Addressing the current hurdles and potential solutions in nonalcoholic steatohepatitis awareness and clinical trial enrollment.
Cathleen Dohrn, Senior Scientific Director for Continuum Clinical, describes the momentous challenges in clinical trials presented by low awareness of nonalcoholic steatohepatitis.
A sex-bias that significantly impacts the advancement of women’s health exists in both preclinical and clinical research.
Published: January 23rd 2018 | Updated:
Published: June 17th 2019 | Updated:
Published: July 1st 2019 | Updated: